Abbott Laboratories (FRA:ABL)
116.50
+0.38 (0.33%)
Last updated: Jun 3, 2025
Abbott Laboratories Revenue
Abbott Laboratories had revenue of $10.36B USD in the quarter ending March 31, 2025, with 3.95% growth. This brings the company's revenue in the last twelve months to $42.34B, up 5.00% year-over-year. In the year 2024, Abbott Laboratories had annual revenue of $41.95B with 4.59% growth.
Revenue (ttm)
$42.34B
Revenue Growth
+5.00%
P/S Ratio
5.21
Revenue / Employee
$371.44K
Employees
114,000
Market Cap
204.08B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 41.95B | 1.84B | 4.59% |
Dec 31, 2023 | 40.11B | -3.54B | -8.12% |
Dec 31, 2022 | 43.65B | 578.00M | 1.34% |
Dec 31, 2021 | 43.08B | 8.47B | 24.47% |
Dec 31, 2020 | 34.61B | 2.70B | 8.48% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SAP SE | 35.15B |
Siemens Aktiengesellschaft | 77.82B |
Deutsche Telekom AG | 120.25B |
Allianz SE | 107.35B |
Rheinmetall AG | 10.48B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.84B |
Siemens Energy AG | 37.44B |
Siemens Healthineers AG | 23.14B |
Abbott Laboratories News
- 10 days ago - Best Dividend Aristocrats For June 2025 - Seeking Alpha
- 10 days ago - Abbott Receives FDA Approval for Tendyne™, First-of-Its-Kind Device to Replace the Mitral Valve Without Open-Heart Surgery - PRNewsWire
- 11 days ago - Abbott Laboratories: Why Wall Street's Skepticism Misses The Real Story - Seeking Alpha
- 16 days ago - Senseonics Holdings, Inc. Announces Closing of Public Offering, Including Exercise in Full of the Underwriters' Option to Purchase Additional Shares, and Closing of Private Placement - Benzinga
- 22 days ago - Abbott India's quarterly profit climbs 28% on strong demand - Reuters
- 22 days ago - Abbott's Libre® Technology is First Continuous Glucose Monitor Associated with Reduced Hospitalizations for Heart Complications in People with Diabetes - PRNewsWire
- 24 days ago - Recent Filing Shows That Rep. Bruce Westerman Sold Over $137K Worth of Apple Stock - Benzinga
- 4 weeks ago - Abbott Labs CEO on federal health care spending, investing in healthy people and weight loss drugs - CNBC